{'fraction_non_alphanumeric': 0.027855153203342618, 'fraction_numerical': 0.019498607242339833, 'mean_word_length': 4.063380281690141, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Glucagon stimulation of human growth hormone.

ABSTRACT Glucagon was administered to 20 volunteers as a 1 mg iv bolus, a 2 mg iv bolus, a 1 mg subcutaneous (sc) injection, and a 1 mg infusion. All 4 tests were followed by a significant human growth hormone (HGH) rise. In response to the 1 mg ½ hr infusion and the 1 mg sc injection, the rise was large, reproducible, and occurred in all tested subjects. The rise in HGH following the bolus injections was small. In response to bolus glucagon, 50% of the tested subjects did not exhibit an HGH rise greater than 2 ng/ml. It was concluded that either a 1 mg sc injection or a 1 mg ½ hr infusion of glucagon is a useful test in studying pituitary growth hormone release.